American Society of Hirudotherapy

Novel use of a hemostatic dressing in the management of a bleeding leech bite: a case report and review of the literature

Research article published in Wilderness & environmental medicine (2012)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportClinical TrialsFedor PJ · Wilderness & environmental medicine, 2012

Abstract

Persistent bleeding from leech bites is a common occurrence, although little evidence is available to guide management. Detailed here is the case of a 30-year-old American man who presented with two leech bites after a trek through the jungle in Nepal, one of which continued to briskly ooze blood despite standard wound care. The wound was ultimately treated with QuikClot gauze, which allowed for rapid hemostasis without rebleeding. This case report describes the first use of a hemostatic dressing for this purpose, and reviews what is known about hemostatic agents and about leeches in order to discuss how they make us bleed and what to do when a leech bite occurs.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal ArticleReview
Indexed MeSH termsAdultAnimalsBites and StingsHemorrhageHemostatic TechniquesHumansLeechesMaleOcclusive DressingsTreatment Outcome

Summary

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This case report describes a 30-year-old man with two leech bites acquired during a jungle trek in Nepal, one of which kept oozing despite standard wound care and was successfully controlled with QuikClot hemostatic gauze, achieving rapid hemostasis without rebleeding; the authors note this as the first reported use of a hemostatic dressing for this purpose. It is directly relevant to hirudotherapy practice because persistent post-bite bleeding (driven by the leech's anticoagulant and antiplatelet secretome) is an expected, sometimes troublesome consequence of clinical leeching, and the report offers a concrete management option alongside its review of leech bleeding mechanisms and hemostatic agents. Caveat: this is a single naturally-acquired bite, not therapeutic Hirudo medicinalis application, and a single case cannot establish that hemostatic dressings are generally superior to standard measures for managing leech-bite bleeding.

Citation

Novel use of a hemostatic dressing in the management of a bleeding leech bite: a case report and review of the literature.

Fedor PJ · Wilderness & environmental medicine, 2012

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.